CapsulesCapsules
Schedule H (Prescription Required)Anxiolytics & SedativesCode: 2675

Cyclobenzaprine Extended-release Capsules 15mg

Generic Formulation:Cyclobenzaprine Extended-release Capsules 15mg
Pack Size:10's

MRP Under Process

Official PMBI MRP is being updated for catalog code 2675.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Cyclobenzaprine Hydrochloride is a centrally acting skeletal muscle relaxant structurally related to tricyclic antidepressants. It acts primarily at the brainstem level to reduce tonic somatic motor activity through descending serotonergic and noradrenergic pathways, relieving acute voluntary muscle spasm without interfering with peripheral muscle function. Indicated for short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2675.Report inaccuracy

Usage Guidelines

Take orally with water, with or without meals. Extended-release capsules should be taken once daily at approximately the same time, swallowed whole. Intended strictly for short-term use (up to 2 to 3 weeks).

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Dry mouth, dizziness, drowsiness, fatigue, headache, constipation. Rare/Severe: Serotonin syndrome (when combined with serotonergic drugs), cardiac arrhythmias, and urinary retention.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in acute post-myocardial infarction, cardiac conduction disturbances, congestive heart failure, hyperthyroidism, and concurrent MAOIs. Do not use for more than 2-3 weeks. Avoid alcohol.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.